Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia

We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with...

Full description

Saved in:
Bibliographic Details
Main Authors: Yolken, Robert H. (Author) , Bachmann, Silke (Author) , Rouslanova, Inna (Author) , Lillehoj, Erik (Author) , Ford, Glen (Author) , Torrey, Edwin F. (Author) , Schröder, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 01 March 2001
In: Clinical infectious diseases
Year: 2001, Volume: 32, Issue: 5, Pages: 842-844
ISSN:1537-6591
DOI:10.1086/319221
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1086/319221
Get full text
Author Notes:Robert H. Yolken, Silke Bachmann, Inna Rouslanova, Erik Lillehoj, Glen Ford, E. Fuller Torrey, and Johannes Schroeder
Description
Summary:We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects.
Item Description:Gesehen am 07.12.2020
Physical Description:Online Resource
ISSN:1537-6591
DOI:10.1086/319221